Transient macrothrombocytopenia associated with maternal-neonatal HPA-21bw incompatibility.

[1]  K. Kawa,et al.  The first two cases of neonatal alloimmune thrombocytopenia associated with the low‐frequency platelet antigen HPA‐21bw (Nos) in Japan , 2012, Transfusion.

[2]  R. Aster,et al.  The human platelet antigen‐21bw is relatively common among Asians and is a potential trigger for neonatal alloimmune thrombocytopenia , 2012, Transfusion.

[3]  P. Nurden,et al.  Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models. , 2011, Blood.

[4]  Y. Tomiyama,et al.  Heterozygous ITGA2B R995W mutation inducing constitutive activation of the αIIbβ3 receptor affects proplatelet formation and causes congenital macrothrombocytopenia. , 2011, Blood.

[5]  R. Aster,et al.  New low‐frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia , 2010, Transfusion.

[6]  P. Noris,et al.  Dominant inheritance of a novel integrin β3 mutation associated with a hereditary macrothrombocytopenia and platelet dysfunction in two Italian families , 2009, Haematologica.

[7]  J. Kelton,et al.  Diagnosis and management of neonatal alloimmune thrombocytopenia. , 2008, Transfusion medicine reviews.

[8]  R. Aster,et al.  Human platelet antigen‐specific alloantibodies implicated in 1162 cases of neonatal alloimmune thrombocytopenia , 2004, Transfusion.

[9]  V. Blanchette,et al.  Alloimmunization to the PIA1 platelet antigen: results of a prospective study , 1990, British journal of haematology.

[10]  W. Rosse,et al.  Alloantibody‐induced platelet serotonin release is blocked by antibody to the platelet PL antigen , 1986, British journal of haematology.

[11]  O. Leeksma,et al.  Effect of the Binding of Anti‐Zwa Antibodies on Platelet Function , 1984, Vox sanguinis.